Potent Neutralization of Staphylococcal Enterotoxin B by Synergistic Action of Chimeric Antibodies
- 1 June 2010
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 78 (6), 2801-2811
- https://doi.org/10.1128/iai.01121-09
Abstract
Staphylococcal enterotoxin B (SEB), a shock-inducing exotoxin synthesized by Staphylococcus aureus , is an important cause of food poisoning and is a class B bioterrorism agent. SEB mediates antigen-independent activation of a major subset of the T-cell population by cross-linking T-cell receptors (TCRs) with class II major histocompatibility complex (MHC-II) molecules of antigen-presenting cells, resulting in the induction of antigen independent proliferation and cytokine secretion by a significant fraction of the T-cell population. Neutralizing antibodies inhibit SEB-mediated T-cell activation by blocking the toxin's interaction with the TCR or MHC-II and provide protection against the debilitating effects of this superantigen. We derived and searched a set of monoclonal mouse anti-SEB antibodies to identify neutralizing anti-SEB antibodies that bind to different sites on the toxin. A pair of non-cross-reactive, neutralizing anti-SEB monoclonal antibodies (MAbs) was found, and a combination of these antibodies inhibited SEB-induced T-cell proliferation in a synergistic rather than merely additive manner. In order to engineer antibodies more suitable than mouse MAbs for use in humans, the genes encoding the VL and VH gene segments of a synergistically acting pair of mouse MAbs were grafted, respectively, onto genes encoding the constant regions of human Igκ and human IgG1, transfected into mammalian cells, and used to generate chimeric versions of these antibodies that had affinity and neutralization profiles essentially identical to their mouse counterparts. When tested in cultures of human peripheral blood mononuclear cells or splenocytes derived from HLA-DR3 transgenic mice, the chimeric human-mouse antibodies synergistically neutralized SEB-induced T-cell activation and cytokine production.Keywords
This publication has 51 references indexed in Scilit:
- Different Preparations of Intravenous Immunoglobulin Vary in Their Efficacy to Neutralize Streptococcal Superantigens: Implications for Treatment of Streptococcal Toxic Shock SyndromeClinical Infectious Diseases, 2006
- Intranasal Exposure to Bacterial Superantigens Induces Airway Inflammation in HLA Class II Transgenic MiceInfection and Immunity, 2006
- Human Leukocyte Antigen-DQ8 Transgenic Mice: a Model To Examine the Toxicity of Aerosolized Staphylococcal Enterotoxin BInfection and Immunity, 2005
- In Vitro and In Vivo Evaluation of Staphylococcal Superantigen Peptide AntagonistsInfection and Immunity, 2004
- Modeling of receptor mimics that inhibit superantigen pathogenesisJournal of Molecular Recognition, 2004
- Design of Chimeric Receptor Mimics with Different TcRVβ IsoformsJournal of Biological Chemistry, 2004
- THE STRUCTURAL BASIS OF T CELL ACTIVATION BY SUPERANTIGENSAnnual Review of Immunology, 1999
- Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B.The Journal of Experimental Medicine, 1994
- T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.The Journal of Experimental Medicine, 1992
- Superantigens: Mechanism of T-Cell Stimulation and Role in Immune ResponsesAnnual Review of Immunology, 1991